Roden DM - Search Results

1

Stereoselective disposition and pharmacologic activity of propafenone enantiomers.

Kroemer HK, Funck-Brentano C, Silberstein DJ, Wood AJ, Eichelbaum M, Woosley RL, Roden DM. Kroemer HK, et al. Among authors: roden dm. Circulation. 1989 May;79(5):1068-76. doi: 10.1161/01.cir.79.5.1068. Circulation. 1989. PMID: 2713973

2

The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.

Lee JT, Kroemer HK, Silberstein DJ, Funck-Brentano C, Lineberry MD, Wood AJ, Roden DM, Woosley RL. Lee JT, et al. Among authors: roden dm. N Engl J Med. 1990 Jun 21;322(25):1764-8. doi: 10.1056/NEJM199006213222502. N Engl J Med. 1990. PMID: 1971708 Free article. Clinical Trial.

3

Stereoselective determination of flecainide in human plasma by high-performance liquid chromatography with fluorescence detection.

Turgeon J, Kroemer HK, Prakash C, Blair IA, Roden DM. Turgeon J, et al. Among authors: roden dm. J Pharm Sci. 1990 Feb;79(2):91-5. doi: 10.1002/jps.2600790202. J Pharm Sci. 1990. PMID: 2109058

4

Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.

Murray KT, Reilly C, Koshakji RP, Roden DM, Lineberry MD, Wood AJ, Siddoway LA, Barbey JT, Woosley RL. Murray KT, et al. Among authors: roden dm. J Clin Invest. 1990 Mar;85(3):836-42. doi: 10.1172/JCI114510. J Clin Invest. 1990. PMID: 2155929 Free PMC article.

5

Propafenone.

Funck-Brentano C, Kroemer HK, Lee JT, Roden DM. Funck-Brentano C, et al. Among authors: roden dm. N Engl J Med. 1990 Feb 22;322(8):518-25. doi: 10.1056/NEJM199002223220806. N Engl J Med. 1990. PMID: 2405273 Review. No abstract available.

6

Flecainide enantiomers: disposition in human subjects and electrophysiologic actions in vitro.

Kroemer HK, Turgeon J, Parker RA, Roden DM. Kroemer HK, et al. Among authors: roden dm. Clin Pharmacol Ther. 1989 Nov;46(5):584-90. doi: 10.1038/clpt.1989.189. Clin Pharmacol Ther. 1989. PMID: 2510963

7

Acute electrophysiologic effects of sodium administration in dogs treated with O-desmethyl encainide.

Bajaj AK, Woosley RL, Roden DM. Bajaj AK, et al. Among authors: roden dm. Circulation. 1989 Oct;80(4):994-1002. doi: 10.1161/01.cir.80.4.994. Circulation. 1989. PMID: 2551538

8

Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.

Funck-Brentano C, Kroemer HK, Pavlou H, Woosley RL, Roden DM. Funck-Brentano C, et al. Among authors: roden dm. Br J Clin Pharmacol. 1989 Apr;27(4):435-44. doi: 10.1111/j.1365-2125.1989.tb05391.x. Br J Clin Pharmacol. 1989. PMID: 2719900 Free PMC article.

9

Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.

Roden DM, Lee JT, Woosley RL, Echt DS. Roden DM, et al. Circulation. 1989 Nov;80(5):1247-58. doi: 10.1161/01.cir.80.5.1247. Circulation. 1989. PMID: 2805262

10

Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.

Barbey JT, Thompson KA, Echt DS, Woosley RL, Roden DM. Barbey JT, et al. Among authors: roden dm. Circulation. 1988 Feb;77(2):380-91. doi: 10.1161/01.cir.77.2.380. Circulation. 1988. PMID: 3123092 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

820 results

Search Page

Filters